Receive News & Ratings for Healthways Inc. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Healthways, Inc. (TVTY) Issues Earnings Results

Healthways, Inc. (NASDAQ:TVTY) posted its earnings results on Thursday. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.03, Briefing.com reports. The business had revenue of $138.90 million for the quarter, compared to the consensus estimate of $138.15 million. Healthways had a negative net margin of 18.90% and a positive return on equity of 37.59%. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. Healthways updated its FY17 guidance to $1.55-1.58 EPS.

Receive News & Ratings for Healthways Inc. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Healthways (NASDAQ:TVTY) traded up 3.68% during mid-day trading on Friday, reaching $40.80. 1,107,628 shares of the company were exchanged. Healthways has a 1-year low of $15.56 and a 1-year high of $41.55. The stock has a 50-day moving average of $39.08 and a 200 day moving average of $31.40. The firm’s market capitalization is $1.60 billion.

WARNING: “[[title]]” was published by [[site]] and is the sole property of of [[site]]. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at [[permalink]].

TVTY has been the topic of a number of analyst reports. ValuEngine raised shares of Healthways from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Zacks Investment Research raised shares of Healthways from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a research report on Tuesday, May 2nd. UBS AG lifted their price objective on shares of Healthways from $37.00 to $43.00 and gave the stock a “buy” rating in a research report on Friday, June 23rd. Jefferies Group LLC reaffirmed a “buy” rating and issued a $36.00 price objective on shares of Healthways in a research report on Friday, June 16th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $34.00 price objective on shares of Healthways in a research report on Friday, April 28th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $35.25.

In other Healthways news, Director Mary Jane England sold 1,763 shares of the stock in a transaction that occurred on Wednesday, May 3rd. The shares were sold at an average price of $31.95, for a total value of $56,327.85. Following the transaction, the director now directly owns 19,453 shares in the company, valued at $621,523.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 8.42% of the company’s stock.

About Healthways

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.